Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationGraft vs Host DiseaseTransplantation, AutologousTransplantation ConditioningHematologic NeoplasmsHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanAntigens, CD34Immunosuppressive AgentsTreatment OutcomeLeukapheresisBone MarrowVidarabineRecurrenceBone Marrow CellsWhole-Body IrradiationHematopoietic Stem CellsHistocompatibilityLeukemiaHistocompatibility TestingGraft vs Leukemia EffectStem Cell TransplantationStem CellsRetrospective StudiesBlood Component RemovalSurvival AnalysisCyclophosphamideCombined Modality TherapyMelphalanMyeloablative AgonistsAnemia, AplasticChronic DiseaseBone Marrow PurgingMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisRemission InductionT-LymphocytesCord Blood Stem Cell TransplantationDisease-Free SurvivalTransplantation, IsogeneicHLA AntigensTime FactorsBlood CellsCytomegalovirus InfectionsBone and BonesTransplantation ImmunologyLeukemia, Myeloid, AcuteBone Marrow DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEtoposideBlood Cell CountCyclosporineLymphocyte DepletionLeukocyte TransfusionKidney TransplantationSurvival RateHematologic DiseasesAcute DiseaseImmunosuppressionInfectionLiver TransplantationOpportunistic InfectionsLymphocyte TransfusionSalvage TherapyTransplantationCytarabineMyelodysplastic SyndromesThiotepaAntineoplastic Agents, AlkylatingFlow CytometryHodgkin DiseaseImmunocompromised HostGraft RejectionLeukemia, MyeloidColony-Forming Units AssayMice, Inbred C57BLLymphomaHepatic Veno-Occlusive DiseaseFollow-Up StudiesLeukocyte CountBlood DonorsCell SeparationPlatelet CountFatal OutcomeRecombinant ProteinsCell DifferentiationImmunophenotypingCarmustineCells, CulturedGraft vs Tumor Effect